Safety of HIV medications – new podcast out now

In focus / 04 May 2022

Henry Zakumumpa from Makerere University School of Public Health airs his research on HIV care and treatment strategies in Uganda and the need for more robust pharmacovigilance.


With the right care, people infected with HIV can lead long and healthy lives. But as with any life-long medical treatment, it is important to acknowledge and manage any side effects.  

In the latest episode of Drug Safety Matters, Henry Zakumumpa from Makerere University School of Public Health tells podcast host Federica Santoro about the potential harms of new HIV therapies and the challenges faced by pharmacovigilance specialists in Uganda. 

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Related Articles

Ecopharmacovigilance: Ensuring environmental safety from pharmaceuticals

To genotype or not to genotype, that is the question

Making fewer medication errors – Education and training remain key

You may also like

To genotype or not to genotype, that is the question

Our genes contribute anything from 15 to 95% of how we react to medicines. Why is this the case, and when is genetic testing necessary to avoid the risk of potential side effects?

21 August 2024

Making fewer medication errors – Education and training remain key

Medication errors significantly contribute to the global number of ADRs per year. How may we best prepare the pharmacovigilance community to tackle the problem?

02 April 2024

Ecopharmacovigilance: Ensuring environmental safety from pharmaceuticals

Pharmacovigilance monitors the safety of the medicines we use, but what about those that get into our environment?

15 October 2024